低碳水饮食对血糖结局影响的随机对照试验方案(ADEPT):针对HbA1c升高人群
该随机对照试验旨在研究通过行为干预和关键食物补充实现的健康低碳水饮食与常规饮食相比,对未使用降糖药物且HbA1c在6.0%至6.9%之间的个体HbA1c及其他代谢危险因素的影响。150名参与者随机分为干预组或对照组,为期6个月。主要结局是干预组与常规饮食组从基线到6个月HbA1c变化的差异。
要点
- 健康低碳水饮食目标:前3个月净碳水化合物<40克,第3至6个月<40至60净克。
- 研究人群为HbA1c 6.0-6.9%且未使用降糖药物的个体。
- 主要结局为6个月时HbA1c变化组间差异,采用意向性治疗分析。
核心结论
- 该试验将评估健康低碳水饮食对未用药但HbA1c升高个体血糖结局的影响。
研究设计与样本
- 随机对照平行试验,150名参与者随机分入干预组或对照组,为期6个月。
- 干预组接受行为干预和关键食物补充以实现健康低碳水饮食,对照组接受常规饮食。
关键数值与推荐
- 干预组低碳水饮食目标:前3个月净碳水化合物<40克,第3至6个月<40至60净克。
- 主要结局为从基线到6个月HbA1c变化的组间差异。
- 次要结局包括6个月空腹血糖、收缩压、总胆固醇与高密度脂蛋白胆固醇比值及体重的组间变化差异。
- 探索性结局包括6个月空腹胰岛素、胰岛素抵抗稳态模型评估、舒张压、腰围及10年心血管疾病风险的组间变化差异。
- 采用意向性治疗分析。
临床怎么用
- 若试验证实有效,健康低碳水饮食可作为减少心血管代谢疾病风险的饮食策略。
- 干预结合行为咨询并促进摄入可能降低心血管代谢疾病风险的膳食成分,预期适用于临床实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality globally. Strong evidence supports the importance of diet and other lifestyle factors in preventing T2DM. Among individuals with T2DM, low-carbohydrate diets lead to decreases in hemoglobin A1c (HbA1c). However, research on the effects of low-carbohydrate diets on glycemic outcomes among individuals not currently on glucose-lowering medications who have elevated HbA1c is limited. METHODS: The objective of this randomized controlled trial is to study the effect of a healthy low-carbohydrate diet achieved through behavioral intervention and key food supplementation compared with usual diet on HbA1c and other metabolic risk factors among individuals with HbA1c from 6.0 to 6.9% who are not on glucose-lowering medications. In this parallel trial, 150 participants will be randomized to the intervention or control group for 6 months. The healthy low-carbohydrate diet target is < 40 g of net carbohydrates during the first 3 months and < 40 to 60 net grams for months 3 to 6. This diet is characterized by abundant unsaturated fat and protein, high-fiber foods such as non-starchy vegetables and nuts, and minimal refined carbohydrates. The primary outcome is the difference in HbA1c change from baseline to 6 months in the intervention compared with usual diet group. Secondary outcomes include differences between groups in 6-month changes in fasting glucose, systolic blood pressure, total-to-high-density lipoprotein (HDL) cholesterol ratio, and body weight. Exploratory outcomes include differences in 6-month changes in fasting insulin, homeostasis model assessment of insulin resistance, diastolic blood pressure, waist circumference, and 10-year cardiovascular disease risk. An intention-to-treat analysis will be used. DISCUSSION: We expect that the results from this study will lead to new approaches for developing and implementing dietary approaches (other than the most commonly used reduced fat diet) that will substantially reduce risk of cardiometabolic disease among adults with or at high risk of T2DM. The study intervention involves behavioral counseling and promotes consumption of dietary components thought to reduce risk of cardiometabolic disease and has expected applicability in clinical practice. TRIAL REGISTRATION: ClinicalTrials.gov NCT03675360 . Registered on September 18, 2018 (prior to enrolment of the first participant).
引用
- Dorans KS, Bazzano LA, Qi L, et al. Low-carbohydrate dietary pattern on glycemic outcomes trial (ADEPT) among individuals with elevated hemoglobin A1c: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33522954. doi:10.1186/s13063-020-05001-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。